Topics:
endostatins, endothelial cells, morphogenesis, pericytes

On page 1046 in the February 1, 2005, issue, Figure 2 contained incorrect photographs taken from the same tissue section. Two photographs showing tissue sections on day 1 have been removed and one photograph depicting a tissue sample of a mouse receiving endostatin for 30 days has been replaced by another photograph. The correct figure is shown below.

Figure 2
Figure 2. Endostatin inhibits capillary morphogenesis. Immunofluorescence staining for α-smooth muscle actin (red) and Ulex lectin-staining (green) of Matrigels from endostatin-treated and control animals. Note the few pericyte-covered vessels in endostatin-treated animals after 40 days. Scalebars, 50 μm.
View largeDownload PPT

Endostatin inhibits capillary morphogenesis. Immunofluorescence staining for α-smooth muscle actin (red) and Ulex lectin-staining (green) of Matrigels from endostatin-treated and control animals. Note the few pericyte-covered vessels in endostatin-treated animals after 40 days. Scalebars, 50 μm.

Figure 2
Figure 2. Endostatin inhibits capillary morphogenesis. Immunofluorescence staining for α-smooth muscle actin (red) and Ulex lectin-staining (green) of Matrigels from endostatin-treated and control animals. Note the few pericyte-covered vessels in endostatin-treated animals after 40 days. Scalebars, 50 μm.
View largeDownload PPT

Endostatin inhibits capillary morphogenesis. Immunofluorescence staining for α-smooth muscle actin (red) and Ulex lectin-staining (green) of Matrigels from endostatin-treated and control animals. Note the few pericyte-covered vessels in endostatin-treated animals after 40 days. Scalebars, 50 μm.

Close modal
© 2009 by The American Society of Hematology
2009
Sign in via your Institution